Stockreport

Roivant announces $1.5B share buyback, positive Phase 2 data Apr. 02, 2024 9:20 AM ET By: Val Brickates Kennedy , SA News Editor [Seeking Alpha]

SUMITOMO CHEM UNSP/ADR  (SOMMY) 
NASDAQ:AMEX Investor Relations: sumitomo-chem.co.jp/english/ir
PDF Roivant's board has authorized the company to buy back up to $1.5B common shares, including the repurchase of the entire Sumitomo Pharma stake for $648M. The Sumitomo s [Read more]